Early Phase II Study of Uracil–Tegafur Plus Doxorubicin in Patients with Unresectable Advanced Biliary Tract Cancer
2006; Oxford University Press; Volume: 36; Issue: 9 Linguagem: Inglês
10.1093/jjco/hyl075
ISSN1465-3621
AutoresJunji Furuse, Takuji Okusaka, Akihiro Funakoshi, Kenji Yamao, Michitaka Nagase, Hiroshi Ishii, Kohei Nakachi, Hideki Ueno, Masafumi Ikeda, Chigusa Morizane, Yuki Horikawa, Nobumasa Mizuno,
Tópico(s)Gallbladder and Bile Duct Disorders
ResumoBackground: Standard chemotherapy for advanced biliary tract cancer has not been established. The purpose of this study was to evaluate the efficacy and toxicity of a combination chemotherapy of uracil–tegafur (UFT) and doxorubicin in patients with unresectable advanced biliary tract cancer.
Referência(s)